Skip to content

Menu

LexBlog, Inc. logo
CommunitySub-MenuPublishersChannelsProductsSub-MenuBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAboutContactResourcesSubscribeSupport
Join
Search
Close

Regeneron Disclaims an Aflibercept Formulation Patent in Response to Celltrion PGR

March 30, 2022
Laboratory research

PTAB Institutes a Second IPR on Rituxan®-related ’821 Patent

August 1, 2018
US Supreme Court

Immunex Loses Battle Over Institution of Follow-on IPR Petitions

March 23, 2018
https-ptablaw-lexblogplatform-com-wp-content-uploads-sites-769-2017-12-oral-arguments-spectrum-2-png

Supreme Court Oral Argument in Oil States

December 12, 2017

The Potential Impact of the Supreme Court’s Decision in Oil States

November 22, 2017

The Supreme Court’s Decision in Amgen v. Sandoz: Clear Guidance and Open Questions for Biosimilars

July 21, 2017
Connect: https://www.rothwellfigg.com/professionals-jennifer-nockJennifer P.'s Linkedin ProfileEmail
Subscribe: Subscribe via RSS
Blogs
  • Biosimilars Law Bulletin
  • PTAB Law Blog
Firm/Org
  • Rothwell Figg

Jennifer P. Nock

Connect: https://www.rothwellfigg.com/professionals-jennifer-nockJennifer P.'s Linkedin ProfileEmail
Subscribe: Subscribe via RSS
Blogs
  • Biosimilars Law Bulletin
  • PTAB Law Blog
Firm/Org
  • Rothwell Figg
LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • The FTI Award Journal
  • International Dispute Resolution
  • China Law Update Blog
  • Law of The Ledger
  • Antitrust Law Blog
Copyright © 2022, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo